SLC39A8-mediated zinc dyshomeostasis potentiates kidney disease
Proceedings of the National Academy of Sciences · 23.09.2025 · 122 (38)
DOI: 10.1073/pnas.2426352122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 16.09.2025. Verfasst von Zhaoxian Cai und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, School of Public Health, State Key Laboratory of Experimental Hematology, Zhejiang University School of Medicine, Han…. Hauptthemen laut MEDLINE: Zinc, Homeostasis, Cation Transport Proteins, Kidney Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), China Postdoctoral Science Foundation (China Postdoctoral Foundation Project).
Abstract (Originalsprache)
While numerous genetic risk loci are linked to kidney disease, a unifying therapeutic target for diverse renal pathologies remains elusive. Here, through large-cohort polymorphic locus screening, we identify the SLC39A8 A391T variant (rs13107325) as a shared modifier of multiple kidney diseases. Functional characterization using Slc39a8 A391T knock-in mice and kidney-specific Slc39a8 knockout mice reveals that loss of SLC39A8 function reduces renal zinc accumulation, thereby mitigating susceptibility to kidney injury and disease progression. Mechanistically, we demonstrate that perturbed zinc homeostasis drives renal damage, and limiting zinc levels—whether via impaired SLC39A8 activity or direct chelation—activates the zinc–AKT–FOXO1–G6PC axis to confer protection. Critically, zinc chelation with EDTA recapitulates this benefit, significantly preventing and ameliorating experimental acute and chronic kidney disease. These findings establish renal zinc homeostasis as a key therapeutic node, with SLC39A8 and zinc-modulating strategies representing promising avenues for treating a broad range of kidney diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital, School of Public Health, State Key Laboratory of Experimental Hematology, Zhejiang University School of Medicine, Hangzhou 310058, China.
- The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China.
- School of Public Health, Basic Medical Sciences, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, China.
ORCID-Profile: Zhaoxian Cai, Tianyi Wang, Yunxing Su, Shumin Sun, Junxia Min, Fudi Wang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- China Postdoctoral Science Foundation (China Postdoctoral Foundation Project)
Zitieren
APA
Cai, Z., Wu, X., Wang, T., Song, Z., Ni, P., Zhong, M., Su, Y., Xie, E., Sun, S., Lin, Y., Min, J., & Wang, F. (2025). SLC39A8-mediated zinc dyshomeostasis potentiates kidney disease. Proceedings of the National Academy of Sciences, 122(38). https://doi.org/10.1073/pnas.2426352122
Vancouver
Cai Z, Wu X, Wang T, Song Z, Ni P, Zhong M, et al. SLC39A8-mediated zinc dyshomeostasis potentiates kidney disease. Proceedings of the National Academy of Sciences. 2025;122(38). doi:10.1073/pnas.2426352122
BibTeX
@article{Cai2025,
author = {Cai, Zhaoxian and Wu, Xiaotian and Wang, Tianyi and Song, Zijun and Ni, Pu and Zhong, Meijuan and Su, Yunxing and Xie, Enjun and Sun, Shumin and Lin, Yangjun and Min, Junxia and Wang, Fudi},
title = {SLC39A8-mediated zinc dyshomeostasis potentiates kidney disease},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {38},
doi = {10.1073/pnas.2426352122}
}
EUVIMED